HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in nef and gag proteins

AIDS Research and Human Retroviruses

Volumn 29, Issue 2, 2013, Pages 270-278

  Chakraborty, Sajib ^a   Rahman, Taibur ^a   Chakravorty, Rajib ^b   Kuchta, Alison ^c   Rabby, Atai ^a   Sahiuzzaman, Munsi ^a  

^a UNIVERSITY OF DHAKA   (Bangladesh)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEF PROTEIN; PROTEOME;

AMINO ACID SEQUENCE; ARTICLE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DRUG DESIGN; EPITOPE MAPPING; HLA SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; IMMUNOGENICITY; IMMUNOLOGY; PRIORITY JOURNAL;

ANTIGEN PRESENTATION; CONSERVED SEQUENCE; EPITOPES, T-LYMPHOCYTE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84872901392     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0160     Document Type: Article

References (28)

1. Borrow P, Lewicki H, Hahn BH, Shaw GM, and Oldstone MB: Virus-specific CD8 + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-6110. (Pubitemid 24258634)
2. Carmichael A, Jin X, Sissons P, and Borysiewicz L: Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 1993;177:249-256. (Pubitemid 23117074)
3. Goulder PJ and Watkins DI: Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 2008;8:619-630.
4. Zhang C, Cornette JL, Berzofsky JA, and DeLisi C: The organization of human leucocyte antigen class I epitopes in HIV genome products: Implications for HIV evolution and vaccine design. Vaccine 1997;15:1291-1302. (Pubitemid 27397803)
5. Culmann-Penciolelli B, Lamhamedi-Cherradi S, Couillin I, Guegan N, Levy JP, Guillet JG, and Gomard E: Identification of multirestricted immunodominant regions recognized by cytolytic T lymphocytes in the human immunodeficiency virus type 1 Nef protein. J Virol 1994;68:7336-7343. (Pubitemid 24328788)
6. Currier JR, Visawapoka U, Tovanabutra S, Mason CJ, Birx DL, McCutchan FE, and Cox JH: CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: Use of multiple peptide sets increases the detectable breadth of the CTL response. BMC Immunol 2006;7:8.
7. Yusim K, Kesmir C, Gaschen B, Addo MM, Altfeld M, Brunak S, Chigaev A, Detours V, and Korber BT: Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol 2002;76:8757-8768. (Pubitemid 34864071)
8. Carrington M, Apple R, Park L, Mun? oz A, Saah AJ, Goedert JJ, Winkler C, O'Brien SJ, Rinaldo C, Detels R, Blattner W, Phair J, Erlich H, and Mann DL: Influence of combinations of human major histocompatibility complex genes on the course of HIV - 1 infection. Nat Med 1996;2:405-411 (Pubitemid 26193012)
9. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, Hallahan CW, Selig SM, Schwartz D, Sullivani J, and Connors M: HLA B. 5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 2000;97:2709-2714. (Pubitemid 30159236)
10. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, and O'Brien SJ: HLA and HIV-1: Heterozygote advantage and B.*35-Cw.*04 disadvantage. Science 1999;283:1748-1752.
11. Flores-Villanueva PO, Yunis EJ, Delgado JC, Vittinghoff E, Buchbinder S, Leung JY, Uglialoro AM, Clavijo OP, Rosenberg ES, Kalams SA, Braun JD, Boswell SL, Walker BD, and Goldfeld AE: Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci USA 2001;98(9):5140-5145. (Pubitemid 32397096)
12. Carrington M and O'Brien, SJ: The influence of HLA genotype on AIDS. Annu Rev Med 2003;54:535-551. (Pubitemid 37386411)
13. Kiepiela P, et al.: Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004;432:769-775.
14. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, et al.: A whole-genome association study of major determinants for host control of HIV-1. Science 2007;317:944-947. (Pubitemid 47301321)
15. Pereyra F, Jia X, McLaren PJ, Telenti A, De Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, et al.: The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010;330:1551-1557.
16. Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, Rathnavalu P, Moore C, Pfafferott KJ, Hilton L, et al.: Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004;432:769-775.
17. Bihl F, Frahm N, Di Giammarino L, Sidney J, John M, Yusim K, Woodberry T, Sango K, Hewitt HS, Henry L, et al.: Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J Immunol 2006; 176:4094-4101. (Pubitemid 44264388)
18. Costa AIF, Rao X, LeChenadecb E, Baarlea DV, and Kesmirb C: HLA-B molecules target more conserved regions of the HIV-1 proteome. AIDS 2010;24:211-215.
19. Hughes AL and Hughes MK: Self peptides bound by HLA class I molecules are derived from highly conserved regions of a set of evolutionarily conserved proteins. Immunogenetics 1995;41:257-262.
20. da Silva J and Hughes AL: Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: Evidence from the nef gene of human immunodeficiency virus 1 (HIV-1). Mol Biol Evol 1998;15: 1259-1268. (Pubitemid 28452409)
21. Lucchiari-Hartz M, Lindo V, Hitziger N, Gaedicke S, Saveanu L, van Endert PM, Greer F, Eichmann K, and Niedermann G: Differential proteasomal processing of hydrophobic and hydrophilic protein regions: Contribution to cytotoxic T lymphocyte epitope clustering in HIV-1-Nef. Proc Natl Acad Sci USA 2003;100:7755-7760. (Pubitemid 36760042)
22. Schmid BV, Kesmir C, and De Boer RJ: The distribution of CTL epitopes in HIV-1 appears to be random, and similar to that of other proteomes. BMC Evol Biol 2009;9:184.
23. Abraham DJ and Leo AJ: Extension of the fragment method to calculate amino acid zwitterion and side chain partition coefficients. Proteins 1987;2:130-152.
24. Nielsen M, Lundegaard C, Lund O, and Kesmir C: The role of the proteasome in generating cytotoxic T-cell epitopes: Insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 2005;57:33-41. (Pubitemid 40591245)
25. Sidney J, Peters B, Frahm N, Brander C, and Sette A: HLA class I supertypes: A revised and updated classification. BMC Immunol 2008;9:1.
26. Rolland M, Tovanabutra S, deCamp AC, Frahm N, Gilbert PB, Sanders-Buell E, Heath L, Magaret CA, Bose M, Bradfield A, et al.: Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat Med 2011;17:366-371.
27. Wilson SE, Pedersen SL, Kunich JC, Wilkins VL, Mann DL, Mazzara GP, Tartaglia J, Celum CL, and Sheppard HW: Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection. AIDS Res Hum Retroviruses 1998;14:925-937. (Pubitemid 28337481)
28. Haynes BF: HIV vaccines: Where we are and where we are going. Lancet 1996;348:933-937. (Pubitemid 26333853)